Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. TSLA
3. SPY
4. META
5. ABVX
6. NVDA
7. BE
8. MU
9. STZ
10. INTC

Go back to Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
(NASDAQ: RLAY) Delayed: 18.05 -0.66 (3.53%)
Previous Close $18.71    52 Week High $ 
Open $18.43    52 Week Low $ 
Day High $19.00    P/E N/A 
Day Low $17.99    EPS $ 
Volume 1,479,355       

(NASDAQ: RLAY) Delayed: 18.05 -0.66 (3.53%)
Previous Close $18.71    52 Week High $ 
Open $18.43    52 Week Low $ 
Day High $19.00    P/E N/A 
Day Low $17.99    EPS $ 
Volume 1,479,355